SG11201908905SA - Cryopreservation method - Google Patents

Cryopreservation method

Info

Publication number
SG11201908905SA
SG11201908905SA SG11201908905SA SG11201908905SA SG 11201908905S A SG11201908905S A SG 11201908905SA SG 11201908905S A SG11201908905S A SG 11201908905SA SG 11201908905S A SG11201908905S A SG 11201908905SA
Authority
SG
Singapore
Prior art keywords
sol
hbtscs
medium
international
rome
Prior art date
Application number
Inventor
Lola M Reid
Alvaro Domenico
Vincenzo Cardinale
Eugenio Gaudio
Guido Carpino
Original Assignee
Univ North Carolina Chapel Hill
Sapienza Univ Di Roma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ North Carolina Chapel Hill, Sapienza Univ Di Roma filed Critical Univ North Carolina Chapel Hill
Publication of SG11201908905SA publication Critical patent/SG11201908905SA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02Preservation of living parts
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02Preservation of living parts
    • A01N1/0205Chemical aspects
    • A01N1/021Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • A01N1/0226Physiologically active agents, i.e. substances affecting physiological processes of cells and tissue to be preserved, e.g. anti-oxidants or nutrients
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02Preservation of living parts
    • A01N1/0205Chemical aspects
    • A01N1/021Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • A01N1/0221Freeze-process protecting agents, i.e. substances protecting cells from effects of the physical process, e.g. cryoprotectants, osmolarity regulators like oncotic agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0676Pancreatic cells

Abstract

B00 9140 80,00 ._= =-• 7000 50,00 M1A0 30,00 20,00 10 ,00 00 SOL 1 SOL IA SOL 3 NO CPO MEDIUM 0 10.00 9.00 8.00 1.00 6.00 .7:: 5.00 M 4.00 3.00 2.00 1.00 0.00 SOLI SOL 3 NO CRY0 MEDIUM A 10, 0, 00 0 9 —80,0 60,0 50,00 4000 • = 1 30,00 20,00 10,00 0,0 SOLI 50L3 NO MO MEDIUM E 45 E 40 35 =s 330 25 nl.:\" 20 5 CTRL SOL MO SOL 2A SOL 2B 01.3 1 NO MEDIUM C 1.20 1.00 5.0.80 MI.60 9 0.40 :F2 0.20 0.00 (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date 11 October 2018 (11.10.2018) WIPO I PCT Iiiimmomitiaotiolomolmomomil moiflom (10) International Publication Number WO 2018/187439 Al (51) International Patent Classification: A01N 1/02 (2006.01) A61K 47/20 (2006.01) A61K 38/38 (2006.01) C12N 5/00 (2006.01) (21) International Application Number: PCT/US2018/026038 (22) International Filing Date: 04 April 2018 (04.04.2018) (25) Filing Language: English (26) Publication Language: English (30) Priority Data: 62/482,644 06 April 2017 (06.04.2017) US (71) Applicants: THE UNIVERSITY OF NORTH CAR- OLINA AT CHAPEL HILL [US/US]; Office of Com- mercialization and Economic Development, 109 Church Street, Chapel Hill, North Carolina 27516 (US). SAPIEN- ZA UNIVERSITA DI ROMA [IT/IT]; Piazzale Aldo Mo- ro, No. 9, 00185 Roma (IT). (72) Inventors: REID, Lola M.; 3621 Sweeten Creek Road, Chapel Hill, North Carolina 27514 (US). DOMENICO, Al- varo; Via Giuseppe Vasi 18, 00162 Rome (IT). CARDI- NALE, Vincenzo; Viale Regina Margherita, 00171 Rome (IT). GAUDIO, Eugenio; Via G. Tuccimei, 1, 00197 Rome (IT). CARPINO, Guido; Viale Arrigo Boito, 61, 00199 Rome (IT). (74) Agent: VILLACORTA, Gilberto M. et al.; FOLEY & LARDNER LLP, 3000 K Street NM., Suite 600, Washing- ton, District of Columbia 20007-5109 (US). (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, (54) Title: CRYOPRESERVATION METHOD 1-1 N co 00 O C SOL 1 SOL 3 MEDIUM FIGS. 1A-1E (57) : Human biliary tree stem/progenitors (hBTSCs) are being used for cell therapies of patients with liver cirrhosis. A cryopreservation method was established to optimize sourcing of hBTSCs for these clinical programs and that comprises serum-free Kubota's Medium (KM) supplemented with 10% dimethyl sulfoxide (DMSO), -3% recombinant human albumin and 0.1% hyaluronans. Cryopreserved versus freshly isolated hBTSCs were similar in vitro with respect to self-replication, sternness traits, and multipotency. They were able to differentiate to functional hepatocytes, cholangiocytes or pancreatic islets, yielding similar levels of secretion of albumin or of glucose-inducible levels of insulin. Cryopreserved versus freshly isolated hBTSCs were equally able to engraft into immunocompromised mice yielding cells with human-specific gene expression and human albumin levels in murine serum that were higher for cryopreserved than for freshly isolated hBTSCs. The successful cryoypreservation of hBTSCs facilitates establishment of [Continued on next page] WO 2018/187439 Al IMEDIMOMOIDEIREI0131MOBIEHOMEMOIMIE CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG). Declarations under Rule 4.17: as to applicant's entitlement to apply for and be granted a patent (Rule 4.17(11)) Published: with international search report (Art. 21(3)) before the expiration of the time limit for amending the claims and to be republished in the event of receipt of amendments (Rule 48.2(h)) hBTSCs cell banking offering logistical advantages for clinical programs for treatment of liver disease.
SG11201908905S 2017-04-06 2018-04-04 Cryopreservation method SG11201908905SA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762482644P 2017-04-06 2017-04-06
PCT/US2018/026038 WO2018187439A1 (en) 2017-04-06 2018-04-04 Cryopreservation method

Publications (1)

Publication Number Publication Date
SG11201908905SA true SG11201908905SA (en) 2019-10-30

Family

ID=63712283

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10202111093PA SG10202111093PA (en) 2017-04-06 2018-04-04 Cryopreservation method
SG11201908905S SG11201908905SA (en) 2017-04-06 2018-04-04 Cryopreservation method

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SG10202111093PA SG10202111093PA (en) 2017-04-06 2018-04-04 Cryopreservation method

Country Status (12)

Country Link
US (2) US20180295834A1 (en)
EP (1) EP3612027A4 (en)
JP (1) JP2020516257A (en)
KR (1) KR20190141168A (en)
CN (1) CN110913691A (en)
AU (1) AU2018249853A1 (en)
BR (1) BR112019020699A2 (en)
CA (1) CA3057883A1 (en)
IL (1) IL269602B (en)
RU (1) RU2019135079A (en)
SG (2) SG10202111093PA (en)
WO (1) WO2018187439A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112126618B (en) * 2019-06-24 2023-09-12 上海拜羡生物科技有限公司 Method for obtaining human gallbladder stem cells and long-term in vitro culture
WO2021065971A1 (en) * 2019-09-30 2021-04-08 テルモ株式会社 Dilution buffer solution for cryopreserved cells
CN115315182A (en) * 2020-03-27 2022-11-08 上海我武干细胞科技有限公司 Cell preservation solution and kit thereof
CN112514892B (en) * 2020-12-25 2022-06-14 广州赛莱拉干细胞科技股份有限公司 Exosome cryopreservation protection solution and preparation method thereof
US11735303B2 (en) 2021-06-22 2023-08-22 David Haase Apparatus and method for determining a composition of a replacement therapy treatment

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992003046A1 (en) * 1990-08-28 1992-03-05 Somatix Therapy Corporation Improved cell cryopreservation method
JPH07255469A (en) * 1994-03-17 1995-10-09 Kurabo Ind Ltd Frozen storage solution for mammalian cell
EP1728857A3 (en) * 2000-01-19 2007-04-11 The University of North Carolina at Chapel Hill Liver tissue source
JP4705473B2 (en) * 2003-11-06 2011-06-22 株式会社リプロセル Stem cell cryopreservation method and system
KR20200146043A (en) * 2009-10-30 2020-12-31 더 유니버시티 오브 노쓰 캐롤라이나 엣 채플 힐 Multipotent stem cells from the extrahepatic billary tree and methods of isolating same
KR102493613B1 (en) * 2010-05-07 2023-01-31 유니버시티 오브 노스캐롤라이나 앳 채플 힐 Method of engrafting cells from solid tissues
AU2015205872B2 (en) * 2010-05-07 2017-07-06 University Of North Carolina At Chapel Hill Method of engrafting cells from solid tissues
CN107075467B (en) * 2014-09-19 2020-08-21 新加坡科技研究局 Differentiation of hepatocyte-like cells from stem cells

Also Published As

Publication number Publication date
CN110913691A (en) 2020-03-24
RU2019135079A (en) 2021-05-06
EP3612027A4 (en) 2021-02-24
AU2018249853A1 (en) 2019-10-31
CA3057883A1 (en) 2018-10-11
RU2019135079A3 (en) 2021-08-03
KR20190141168A (en) 2019-12-23
BR112019020699A2 (en) 2020-05-12
IL269602A (en) 2019-11-28
SG10202111093PA (en) 2021-11-29
IL269602B (en) 2022-06-01
WO2018187439A1 (en) 2018-10-11
JP2020516257A (en) 2020-06-11
US20180295834A1 (en) 2018-10-18
EP3612027A1 (en) 2020-02-26
US20220232820A1 (en) 2022-07-28

Similar Documents

Publication Publication Date Title
SG11201908905SA (en) Cryopreservation method
SG11201805320XA (en) Materials and methods for treatment of amyotrophic lateral sclerosis and/or frontal temporal lobular degeneration
SG11201804375WA (en) Compositions and methods for internalizing enzymes
SG11201908391XA (en) Methods for modulating an immune response
SG11201810003UA (en) Using programmable dna binding proteins to enhance targeted genome modification
SG11201909322VA (en) Treatment of asthma with anti-tslp antibody
SG11201907870VA (en) Compositions and methods for inhibition of lineage specific proteins
SG11201808125RA (en) Methods for solid tumor treatment
SG11201805420SA (en) Antibodies and conjugates thereof
SG11201807041PA (en) Improved preparations of adult liver progenitor cells
SG11201408124PA (en) Differentiation of human embryonic stem cells into pancreatic endocrine cells
SG11201807593TA (en) Compositions and methods to program therapeutic cells using targeted nucleic acid nanocarriers
SG11201805072PA (en) Nicotine powder delivery system
SG11201808176TA (en) Gene therapy for treating mucopolysaccharidosis type ii
SG11201408261UA (en) Syringe
SG11201805001UA (en) Method of treating influenza a
SG11201807051VA (en) Replication competent attenuated vaccinia viruses with deletion of thymidine kinase with and without the expression of human flt3l or gm-csf for cancer immunotherapy
SG11201408521WA (en) Use of ferric citrate in the treatment of chronic kidney disease patients
SG11201900845YA (en) Uses of il-13 antagonists for treating atopic dermatitis
SG11201806342SA (en) Glucagon and glp-1 co-agonists for the treatment of obesity
SG11201901203PA (en) Treatment and sustained virologic remission of hiv infection by antibodies to cd4 in haart stabilized patients
SG11201909561RA (en) Octree-based convolutional neural network
SG11201805052YA (en) Therapeutic methods using erythrocytes
SG11201901228QA (en) Chromatography method for quantifying a non-ionic surfactant in a composition comprising the non-ionic surfactant and a polypeptide
SG11201805311XA (en) Method of treating a mammal, including human, against cancer using methionine and asparagine depletion